These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Harker LA; Hirsh J; Gent M; Genton E Prog Hematol; 1975; 9():229-54. PubMed ID: 766074 [No Abstract] [Full Text] [Related]
6. The current status of platelet suppressive drugs in the treatment of thrombosis. Hirsh J; Gent M; Genton E Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213 [No Abstract] [Full Text] [Related]
7. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts). Genton E; Gent M; Hirsh J; Harker LA N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986 [No Abstract] [Full Text] [Related]
8. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Turpie AG Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035 [TBL] [Abstract][Full Text] [Related]
10. [Clinical application and evaluation of anti-platelet agents]. Yasunaga K Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628 [No Abstract] [Full Text] [Related]
11. Prevention of thrombosis with antiplatelet drugs. Kahn SB Am Fam Physician; 1980 May; 21(5):166-8. PubMed ID: 7377074 [No Abstract] [Full Text] [Related]
12. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction. Hirsh J Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733 [TBL] [Abstract][Full Text] [Related]
13. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents]. Bousser MG J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494 [TBL] [Abstract][Full Text] [Related]
14. Effect of drugs of platelets and complications of vascular disease. Mustard JF; Packham MA; Kinlough-Rathbone RL Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448 [No Abstract] [Full Text] [Related]
15. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy]. Verstraete M Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244 [No Abstract] [Full Text] [Related]
16. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position. McNicol GP Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840 [No Abstract] [Full Text] [Related]
17. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link. de Gaetano G; Cerletti C; Bertelè V Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469 [No Abstract] [Full Text] [Related]
18. Status of antiplatelet drugs in coronary heart disease. Mehta J; Mehta P JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365 [No Abstract] [Full Text] [Related]